Biotech

All Articles

GSK's long-acting breathing problem medication halved attacks in period 3

.GSK's long-acting breathing problem treatment has actually been actually revealed to halve the numb...

AstraZeneca, Daiichi unpack Dato-DXd's overall survival fall short

.AstraZeneca as well as Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has actually f...

Roivant unveils brand new 'vant' to evolve Bayer hypertension med

.Matt Gline is back along with a new 'vant' company, after the Roivant Sciences CEO spent Bayer $14 ...

Viridian eye health condition stage 3 hits, progressing push to rivalrous Amgen

.Viridian Therapeutics' period 3 thyroid eye disease (TED) scientific trial has struck its primary a...

Bain introduces $3B fund forever science companies

.With a solid record for recognizing diamonds in the rough, Bain Resources Lifespan Sciences (BCLS) ...

Genentech's cancer cells restructure made 'for medical explanations'

.The current choice to combine Genentech's two cancer divisions was actually created "medical explan...

Tern dental GLP-1 reveals 5% fat loss at 1 month at greatest dose

.Terns Pharmaceuticals' choice to lose its liver illness aspirations may yet settle, after the biote...

Merck, Daiichi loyal very early effectiveness in tiny tissue lung cancer cells along with upgraded ADC records

.Merck &amp Co.'s long-running attempt to land a strike on small mobile bronchi cancer (SCLC) has ac...

Boehringer, Bayer breakthrough lung cancer cells medications toward Astra war

.Some patients with non-small tissue bronchi cancer cells (NSCLC) have anomalies in a genetics refer...

MBX pursues $136M IPO to take competitor to Ascendis into phase 3

.MBX has actually elaborated programs to absorb over $136 million coming from its IPO as the biotech...